Roots of clinical resistance to STI-571 cancer therapy.

Science

Volumn 293, Issue 5538, 2001, Pages 2163-

  Barthe, C ^a   Cony Makhoul, P ^a   Melo, J V ^a   Mahon, J R ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; IMATINIB; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

AMINO ACID SUBSTITUTION; ARTICLE; CHEMISTRY; CHRONIC MYELOID LEUKEMIA; DRUG RESISTANCE; GENETICS; HUMAN; METABOLISM; MYELOID LEUKEMIA; ONCOGENE; POINT MUTATION;

AMINO ACID SUBSTITUTION; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; FUSION PROTEINS, BCR-ABL; GENES, ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; PIPERAZINES; POINT MUTATION; PROTO-ONCOGENE PROTEINS C-ABL; PYRIMIDINES;

MLCS; MLOWN;

EID: 0035929652     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.293.5538.2163a     Document Type: Article

References (0)